China Pharma Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of China Pharma Holdings generated cash of -$699,686, which is less than the previous year. Cash used in financing activities reached the amount of $73,145 last year. Net change in cash is therefore -$606,133.
Cash Flow
| 2014 | 4.57M | -5.84M | 605.00K |
|---|---|---|---|
| 2015 | 3.35M | -1.89M | 0 |
| 2016 | 2.89M | -193.40K | -6.02M |
| 2017 | 841.21K | -136.47K | -1.47M |
| 2018 | 1.25M | -51.14K | -1.97M |
| 2019 | 608.31K | -136.00K | -1.72M |
| 2020 | -42.26K | -867.30K | 624.17K |
| 2021 | -249.83K | -438.05K | 4.59M |
| 2022 | -409.54K | -401.96K | -1.77M |
| 2023 | -699.68K | -11.51K | 73.14K |
CPHI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.02M | 4.85M | 957.65K | 1.18M | 2.46M | 2.03M | 2.66M | 6.24M | 5.29M | 5.99M |
Operating activities | ||||||||||
Net income | -3.07M | -3.97M | -3.39M | -2.86M | -20.70M | -10.75M | -19.27M | -9.18M | -15.40M | -26.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.75M | 2.70M | 3.08M | 2.67M | 2.92M | 3.25M | 3.29M | 3.07M | 3.59M | 1.78M |
Stock-based compensation expense | 0 | 78.27K | 15.24K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 78.27K | 15.24K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -938.02K | -170.19K | -106.92K | -733.45K | -1.20M | 99.4K | 51.02K | -172.24K | 319.90K | -4.10M |
Inventories | -25.03K | 689.10K | 1.01M | 807.59K | 1.99M | 688.85K | 1.71M | 2.73M | 5.15M | 12.78M |
Accounts payable | 312.04K | -187.73K | -332.77K | -214.01K | 324.18K | -16.44K | -2.04M | 815.19K | 601.47K | 634.67K |
Cash generated by operating activities | -699.68K | -409.54K | -249.83K | -42.26K | 608.31K | 1.25M | 841.21K | 2.89M | 3.35M | 4.57M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -11.51K | -401.96K | -438.05K | -867.30K | -136.00K | -51.14K | -136.47K | -193.40K | -2.31M | -5.84M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -11.51K | -401.96K | -438.05K | -867.30K | -136.00K | -51.14K | -136.47K | -193.40K | -1.89M | -5.84M |
Financing activities | ||||||||||
Common Stock Issued | 1.65M | 1.70M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 73.14K | -1.54M | -5.41M | -2.43M | -1.72M | -2.26M | -1.47M | -6.02M | 0 | 0 |
Cash used in financing activities | 73.14K | -1.77M | 4.59M | 624.17K | -1.72M | -1.97M | -1.47M | -6.02M | 0 | 605.00K |
Net Change In Cash | -606.13K | -2.82M | 3.90M | -227.23K | -1.27M | -843.62K | -635.58K | -3.58M | 952.97K | -697.34K |
Cash at end of period | 1.42M | 2.02M | 4.85M | 957.65K | 1.18M | 1.18M | 2.03M | 2.66M | 6.24M | 5.29M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |